Israel’s Micromedic Technologies, has identified several new genetic markers for predicting BRONJ (necrosis of the jawbone). BRONJ is a side effect of intravenous treatments in cancer and osteoporosis patients.

http://www.bio-light.co.il/wp-content/uploads/2015/08/BRONJ-PR-clean-updated.pdf

http://biotuesdays.com/2015/08/31/biolight-unit-identifies-bronj-genetic-markers/